Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Guggulsterone has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Guggulsterone is characterised in the pharmacology literature as an antagonist at the farnesoid X receptor, while bile acids such as chenodeoxycholic acid are its natural agonists. Supplying bile acids alongside pushes the same receptor in the opposite direction. This is a genuine directional conflict at one target and deserves flagging in any formula that carries both.
Guggulsterone is a steroid-type molecule with very low water solubility that comes from a gum resin matrix. Phospholipid complexes are a standard way to disperse such molecules and keep them from recrystallising. The effect is on dispersion and dissolution, not on what the molecule does once it reaches a receptor.
A lipid vehicle keeps guggulsterone in solution through gastric transit rather than letting it precipitate. Fat in the meal also drives bile release and micelle formation, which is the route by which lipophilic compounds cross the enterocyte. How much of that translates into blood levels has not been quantified for this molecule in the sources available here.
Red yeast rice supplies monacolin K, which acts on cholesterol synthesis, while guggulsterone acts on nuclear receptor control of bile acid and cholesterol disposal. Different control points on one system can stack. Both also carry meaningful interaction potential with prescribed lipid medicines, so this pairing is one to raise with a clinician rather than assemble alone.
Berberine acts largely through AMPK activation and LDL receptor expression, guggulsterone through nuclear receptor antagonism. The targets do not overlap, which is the usual argument for combining them. Both are also substrates and modifiers of drug-metabolising enzymes, so combined use raises the chance of shifting the levels of prescribed medicines.
Guggulsterone has been reported to activate the pregnane X receptor, which raises expression of CYP3A4 and related transporters. Curcumin is more often described as inhibiting several of the same enzymes. Putting them together makes the net effect on any co-taken medicine hard to predict, which is worth saying plainly.
Silymarin is used for hepatocyte support and guggulsterone acts on bile acid signalling inside the same cell type. Formulators combine them on that logic. No study here tested the combination, so this stays a mechanistic pairing rather than a demonstrated one.
Iodine is the substrate for thyroid hormone synthesis, a settled biochemical requirement. Guggul preparations have been discussed in relation to thyroid hormone handling in older preclinical work of variable quality. Anyone taking thyroid medication should regard this pair as one to clear with a prescriber first.
EPA and DHA act largely on triglyceride synthesis and clearance, guggulsterone on nuclear receptor control of bile acid and sterol disposal. Because the entry points differ, combining them is a common formulation choice. There is no trial of the pair in the sources available here.
Nothing specific on file for Guggulsterone. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Guggulsterone. The full linked list is below.
1 source behind our Guggulsterone verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 137 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Guggulsterone is, not how risky it is. A report is not proof Guggulsterone caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.